2010-06-01
Nephrotoxicity in mice after repeated imaging using 111In- labeled peptides
Publication
Publication
The Journal of Nuclear Medicine , Volume 51 - Issue 6 p. 973- 977
We determined the renal radiation dose of a series of111Inlabeled peptides using animal SPECT. Because the animals' health deteriorated, renal toxicity was assessed. Methods: Wild-type and megalin-deficient mice were imaged repeatedly at 3- to 6-wk intervals to quantify renal retention after injection of 40-50 MBq of111In- diethylenetriaminepentaacetic acid-labeled peptides (octreotide, exendin, octreotate, neurotensin, and minigastrin analogs), and the absorbed kidney radiation doses were estimated. Body weight, renal function parameters, and renal histology were determined at 16-20 wk after the first scan and compared with those in naive animals. Results: Because of high renal retention,111In-diethylenetriaminepentaacetic acid-exendin-4 scans resulted in a 70-Gy kidney radiation dose in wild-type mice. Megalin-deficient kidneys received 20-40 Gy. The other peptides resulted in much lower renal doses. Kidney function monitoring indicated renal damage in imaged animals. Conclusion: Micro-SPECT enables longitudinal studies in 1 animal. However, long-term nephrotoxic effects may be induced after high renal radiation doses, even with111In-labeled radiotracers. COPYRIGHT
Additional Metadata | |
---|---|
, , , , , | |
doi.org/10.2967/jnumed.109.074310, hdl.handle.net/1765/27762 | |
The Journal of Nuclear Medicine | |
Organisation | Erasmus MC: University Medical Center Rotterdam |
Melis, M., Vegt, E., Konijnenberg, M., de Visser, M., Bijster, M., Vermeij, M., … de Jong, M. (2010). Nephrotoxicity in mice after repeated imaging using 111In- labeled peptides. The Journal of Nuclear Medicine, 51(6), 973–977. doi:10.2967/jnumed.109.074310 |